|CRDAMC Homepage | CRDAMC Library Phone #: (254) 288-8366 | CRDAMC Library Fax #: (254) 288-8368|
Chronic Myelocytic Leukemia
(CML; Chronic Myeloid Leukemia; Chronic Myelogenous Leukemia; Chronic Granulocytic Leukemia)
by Krisha McCoy, MS
Chronic myelogenous leukemia (CML) is a cancer of the blood and bone marrow. Under normal circumstances, the bone marrow makes:
CML progresses gradually. It is often slow growing for many years. Over time, it may change into acute myelogenous leukemia (AML). This is a more aggressive type of leukemia. It progresses more rapidly and is more serious.
Cancer occurs when cells in the body become abnormal. They divide without control or order. Leukemia is cancer of the white blood cells and their parent cells. Leukemia cells do not function normally. In this case, they cannot fight infections. This means that the person is more likely to become infected with viruses or bacteria. The cancerous cells also overgrow the bone marrow. This forces other normal cells, like platelets out. Platelets are needed to help the blood clot. As a result, people with leukemia may bleed more easily.
CML is almost always associated with a gene mutation. The gene is in a chromosome called the Philadelphia chromosome. This mutation occurs during life. It is not passed from parent to child. In most cases, the cause of the mutation is not known. Studies show that exposure to large doses of radiation is associated with development of CML. It may be found in survivors of nuclear accidents or of atomic bomb blasts. However, most people with the condition have not been exposed to radiation.
Risk Factors TOP
CML is more common in men and in those of increasing age. Other factors that may increase your chances of CML:
CML may cause:
Your doctor will ask about your symptoms and medical history. A physical exam will be done. Your liver and spleen will be examined for swelling. The doctor will also look for swelling in lymph nodes in the armpits, groin, or neck.
Tests may include:
Imaging tests can evaluate other bodily structures. These can be done with:
Talk with your doctor about the best plan for you. Treatment options include:
Targeted Drug Therapy
Targeted drug therapy inhibits the molecule that triggers the development of leukemia and the gene that is associated with it. This medication is often used in early stages of CML.
Chemotherapy is the use of drugs to kill cancer cells. It may be given by pill, injection, or via a catheter. The drugs enter the bloodstream and travel through the body. While this will focus on cancer cells, some healthy cells are also killed.
High-dose Chemotherapy with Stem Cell Transplant TOP
Chemotherapy is followed by a stem cell transplant. These will replace blood-forming cells destroyed by cancer treatment. Stem cells are removed from the blood or bone marrow of the patient or donor. They are then infused into the patient.
Donor Lymphocyte Infusion TOP
Lymphocytes are a type of white blood cell. A donor’s cells are infused into the patient. The cancer cells do not recognize these cells. They do not attack them.
There are no current guidelines to prevent CML because the cause is unknown.
American Cancer Society
The Leukemia and Lymphoma Society
Canadian Cancer Society
Provincial Health Services Authority
Chronic myeloid leukemia (CML). American Cancer Society website. Available at: https://www.cancer.org/cancer/chronic-myeloid-leukemia.html. Accessed January 8, 2018.
Chronic myeloid leukemia. EBSCO DynaMed Plus website. Available at: http://www.dynamed.... Updated January 4, 2018. Accessed January 8, 2018.
General information about chronic myelogenous leukemia. National Cancer Institute website. Available at: https://www.cancer.gov/types/leukemia/patient/cml-treatment-pdq. Updated March 6, 2017. Accessed January 8, 2018.
Last reviewed December 2017 by EBSCO Medical Review Board Mohei Abouzied, MD, FACP
Last Updated: 12/20/2014
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.